We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
When supplies are strained, what gives? For Merck & Co., in the midst of global production constraints, it's phasing out shipments of cut-rate RotaTeq doses to Africa